Translational Health Research
The Institute's focus is on translational health research, an emerging area of medical science that aims to improve public health through collaborative discoveries and innovations in patient care, education and research.
This innovative 'bench to bedside' approach allows scientific discoveries to be translated into improved patient care and treatment; while information gathered by clinical studies about the nature and progression of disease at the 'bedside' also provides new clues and directions for 'bench' research.
The Institute is part of The Queen Elizabeth Hospital campus, enhancing the opportunities for translational health research and collaboration among laboratory scientists and clinical staff.
Research is conducted by hospital departments and University disciplines based at the Hospital.
The Institute received significant Program Grant funding from The Hospital Research Foundation to establish five collaborative Programs. Three programs have continuing funding until 31 March 2013. Approximately $970,000 has been committed to the following Programs in 2012-13:
- The Health Observatory
- The Centre for Surgical Evidence, Assessment and Training (SEAT)
- The Centre for Inflammatory Disease Research (CIDR) - Program Completed
- The South Australian Translational Centre for Renal Research - Program Completed
- Vascular Diseases and Therapeutics Research Group
The three year Programs for the Centre for Inflammatory Diseases Research and the SA Translational Centre for Renal Research concluded in 2011.
Specialist Research Groups
located at the Basil Hetzel Institute
Virology Research Laboratory - Professor Eric Gowans: The aim of our research is to investigate novel vaccine strategies for hepatitis C virus (HCV) and human immunodeficiency virus (HIV). For more information on the research projects and profiles of Professor Gowans and his staff open the PDF file.
To view the 2014 PostGraduate Projects available in the Virology Laboratory Click Here